D.E. Shaw & Co Portfolio holdings
D. E. Shaw & Co., L.P., founded in 1988 by David E. Shaw, a former Columbia University computer science professor, is a New York City-based global investment management firm renowned for pioneering quantitative investing, managing over $70 billion in assets as of late 2024. Starting with $28 million from Paloma Partners and private investors, the firm employs sophisticated mathematical models and proprietary algorithms—initially developed by a team of scientists and programmers—to exploit market anomalies across public and private markets, including equities, fixed income, and alternatives. Headquartered above a Greenwich Village bookstore in its early days, it now boasts over 2,500 employees across offices in North America, Europe, and Asia, led by a seven-member Executive Committee since Shaw stepped back in 2001 to focus on D. E. Shaw Research. Despite setbacks like the 1998 Russia debt crisis and the 2008 financial downturn, the firm has maintained a reputation for analytical rigor, risk management, and innovation, balancing its computational roots with discretionary strategies.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alibaba
BABA
|
+$667M |
| 2 |
NVIDIA
NVDA
|
+$584M |
| 3 |
ConocoPhillips
COP
|
+$432M |
| 4 |
Amazon
AMZN
|
+$418M |
| 5 |
Johnson & Johnson
JNJ
|
+$377M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Qualcomm
QCOM
|
+$836M |
| 2 |
Meta Platforms (Facebook)
META
|
+$525M |
| 3 |
Apple
AAPL
|
+$453M |
| 4 |
CELG
Celgene Corp
CELG
|
+$349M |
| 5 |
Pfizer
PFE
|
+$306M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 15.58% |
| 2 | Consumer Discretionary | 13.65% |
| 3 | Healthcare | 12.98% |
| 4 | Industrials | 7.3% |
| 5 | Financials | 7.22% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1076
Avanos Medical
AVNS
| $10.5M | 0.01% |
241,338
-146,265
| -38% | -$6.26M |
|
1077
PUT
Capri Holdings
CPRI
$1.89B
| $10.5M | 0.01% |
302,200
+139,000
| +85% | +$5.65M |
|
1078
PUT
Veeva Systems
VEEV
$32.7B
| $10.5M | 0.01% |
64,600
+49,500
| +328% | +$7.21M |
|
1079
SPX Corp
SPXC
$10.3B
| $10.5M | 0.01% |
316,798
-135,889
| -30% | -$4.54M |
|
1080
PUT
Lear
LEA
$7.44B
| $10.5M | 0.01% |
75,100
+27,100
| +56% | +$3.8M |
|
1081
Haemonetics
HAE
$3.76B
| $10.5M | 0.01% |
86,852
-183,756
| -68% | -$18.1M |
|
1082
PUT
Okta
OKTA
$23.6B
| $10.4M | 0.01% |
84,500
+46,500
| +122% | +$5.05M |
|
|
WCG
1083
DELISTED
Wellcare Health Plans, Inc.
WCG
| $10.4M | 0.01% |
36,609
-9,273
| -20% | -$2.56M |
|
|
CHX
1084
DELISTED
ChampionX
CHX
| $10.4M | 0.01% |
310,455
+201,664
| +185% | +$7.32M |
|
1085
Taylor Morrison
TMHC
| $10.4M | 0.01% |
496,745
-172,772
| -26% | -$3.44M |
|
1086
Deckers Outdoor
DECK
$14.1B
| $10.4M | 0.01% |
354,876
-92,106
| -21% | -$2.39M |
|
1087
CBIZ
CBZ
$2.5B
| $10.4M | 0.01% |
530,504
+61,167
| +13% | +$1.23M |
|
1088
Grand Canyon Education
LOPE
$3.98B
| $10.4M | 0.01% |
88,699
-167,418
| -65% | -$20M |
|
|
BHVN
1089
DELISTED
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
| $10.4M | 0.01% |
236,916
+197,879
| +507% | +$11.2M |
|
|
MRSH
1090
Marsh
MRSH
$91.5B
| $10.4M | 0.01% |
103,790
+62,463
| +151% | +$5.98M |
|
1091
Adtran
ADTN
$730M
| $10.3M | 0.01% |
678,228
+248,296
| +58% | +$3.96M |
|
1092
COPT Defense Properties
CDP
$4.34B
| $10.3M | 0.01% |
391,122
-175,808
| -31% | -$4.9M |
|
1093
PUT
Viatris
VTRS
$20.8B
| $10.3M | 0.01% |
541,200
+258,400
| +91% | +$5.71M |
|
1094
V2X
VVX
$2.8B
| $10.2M | 0.01% |
251,955
-14,406
| -5% | -$529K |
|
|
AMAG
1095
DELISTED
AMAG Pharmaceuticals
AMAG
| $10.2M | 0.01% |
1,022,054
-15,705
| -2% | -$169K |
|
1096
Charter Communications
CHTR
$16.6B
| $10.2M | 0.01% |
25,787
+2,130
| +9% | +$798K |
|
1097
Belden
BDC
$4.05B
| $10.2M | 0.01% |
170,898
-9,250
| -5% | -$531K |
|
|
SIVB
1098
DELISTED
SVB Financial Group
SIVB
| $10.2M | 0.01% |
45,292
-58,636
| -56% | -$13.6M |
|
|
SFIX
1099
Stitch Fix
SFIX
$555M
| $10.2M | 0.01% |
317,892
-391,072
| -55% | -$10.5M |
|
|
PDCE
1100
DELISTED
PDC Energy, Inc.
PDCE
| $10.2M | 0.01% |
281,714
+240,717
| +587% | +$9.08M |
|
Similar funds
D.E. Shaw & Co's Q2 2019 Portfolio in Review
As of Q2 2019, D.E. Shaw & Co held 4,048 positions worth $80.2B, up 3.6% from $77.4B the previous quarter. Its ten largest holdings account for 9.8% of the portfolio.
D.E. Shaw & Co's Q2 2019 filing shows 499 new, 1,419 increased, 1,452 reduced and 416 closed positions. Its largest new stake was Zayo Group Holdings, Inc.: 5,926,898 shares worth $195M. The largest sale was Qualcomm, an estimated $836M.
By sector, the portfolio is most concentrated in Technology at 16% of assets, down from 16% a quarter earlier, followed by Consumer Discretionary and Healthcare.
- D.E. Shaw & Co's largest Q2 2019 buy was Zayo Group Holdings, Inc.: 5,926,898 shares worth $195M.
- D.E. Shaw & Co added most to Alibaba in Q2 2019, an estimated $667M increase.
- D.E. Shaw & Co's biggest Q2 2019 reduction was Qualcomm, cutting an estimated $836M.
- D.E. Shaw & Co fully exited iShares Core S&P 500 ETF in Q2 2019, selling an estimated $42.7M.
- D.E. Shaw & Co's ten largest holdings make up 9.8% of its $80.2B portfolio in Q2 2019.
- D.E. Shaw & Co opened 499 new positions and closed 416 in Q2 2019.
- D.E. Shaw & Co's portfolio value rose 3.6% quarter-over-quarter to $80.2B.
Based on D.E. Shaw & Co's 13F filing for Q2 2019, filed 14 Aug 2019.